MedTrace Logo

Omega-3 Treatment for Concussion in Adolescents

NCT05847608 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-06-23

No results posted yet for this study

Summary

The goal of this clinical trial is to test omega-3 fatty acid supplementation as a treatment in adolescents with a concussion. The main questions it aims to answer are:

* Does supplementing with omega-3 fatty acids improve time to recovery following sport related concussion.
* Does supplementing with omega-3 fatty acids improve health related quality of life following concussion.
* Does supplementing with omega-3 fatty acids change post-concussion symptoms following concussion.
* Does supplementing with omega-3 fatty acids change saliva concentrations of interleukin-6 following concussion.
* Does supplementing with omega-3 fatty acids change saliva concentrations of cortisol following concussion.

Participants will be randomized to receive either an omega-3 supplement or placebo after they have been diagnosed with a concussion. Researchers will compare the omega-3 supplement group and placebo group to see if omega-3 fatty acids, consumed as a treatment, can improve time to recovery, health related quality of life and symptom burden, and whether omega-3 fatty acids alter interleukin-6 and cortisol concentrations in saliva following a concussion.

Conditions

  • Concussion, Mild

Interventions

DIETARY_SUPPLEMENT

Omega-3

Daily consumption of 500 mg DHA and 750 mg EPA in liquid form

DIETARY_SUPPLEMENT

Placebo

Oleic Acid, Linoleic Acid

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Stephen Cornish, PhD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05847608 on ClinicalTrials.gov